Distinct activities of p52/NF-κB required for proper secondary lymphoid organ microarchitecture: Functions enhanced by Bcl-3

Journal of Immunology

Volumn 163, Issue 12, 1999, Pages 6581-6588

  Poljak, Ljiljana ^a   Carlson, Louise ^a   Cunningham, Kirk ^a   Kosco Vilbois, Marie H ^b   Siebenlist, Ulrich ^a,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; PROTEIN BCL 3; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ARTICLE; DENDRITIC CELL; IMMUNOHISTOCHEMISTRY; LYMPHOID ORGAN; MOUSE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADJUVANTS, IMMUNOLOGIC; ADOPTIVE TRANSFER; ANIMALS; ANTIGEN-ANTIBODY COMPLEX; BASEMENT MEMBRANE; BONE MARROW TRANSPLANTATION; CHEMOKINES, CXC; DENDRITIC CELLS, FOLLICULAR; GENE EXPRESSION REGULATION; LYMPHOID TISSUE; MACROPHAGES; MICE; MICE, KNOCKOUT; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROTO-ONCOGENE PROTEINS; SPLEEN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0032736186     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell. Biol. 10:405.
2. Baldwin, A. S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.
3. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225.
4. Gerondakis, S., R. Grumont, I. Rourke, and M. Grossmann. 1998. The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation. Curr. Opin. Immunol. 10:353.
5. Sha, W. C., H. C. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321.
6. Kontgen, F., R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965.
7. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with targeted disruption of RelB. a member of the NF-κB/ Rel family. Cell 80:331.
8. Doi, T. S., T. Takahashi, O. Taguchi, T. Azuma, and Y. Obata. 1997. NF-κB RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185:953.
9. Fransozo, G., L. Carlson, L. Poljak, E. W. Shores, S. Epstein, A. Leonardi, A. Grinberg, T. Tran, T. Sharton-Kersten, M. Anver, P. Love, K. Brown, and U. Siebenlist. 1998. Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions and splenic microarchitecture. J. Exp. Med. 187:147.
10. Caamano, J. H., C. A. Rizzo, S. K. Durham, D. S. Barton, C. Raventos-Suarez, C. M. Snaper, and R. Bravo. 1998. Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187:185.
11. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167.
12. Burkly, L., C. Hession, L. Ogata, C. Reilly, L. A. Marconi, D. Olsen, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for development of thymic medulla and dendritic cells. Nature 373:531.
13. Belwin, M. P., and K. V. Anderson. 1996. A conserved signaling pathway: the Drosophila Toll-dorsal pathway. Annu. Rev. Cell. Dev. Biol. 12:393.
14. Brown, K., S. Park, T. Kanno, G. Fransozo, and U. Siebenlist. 1993. Mutual regulation of the transcriptional coactivator NF-κB and its inhibitor IκBα. Proc. Natl. Acad. Sci. USA 90:2532.
15. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB proteolysis by site-specific signal-induced phosphorylation. Science 267:1485.
16. May, M. J., and S. Ghosh. 1997. Rel/NF-κB and IκB proteins: an overview. Semin. Cancer Biol. 8:63.
17. Whiteside, S. T., and A. Israel. 1997. IκB proteins: structure, function and regulation. Semin. Cancer Biol. 2:75.
18. Tarlinton, D. 1998. Germinal centers: form and function. Curr. Opin. Immunol. 10:245.
19. Huguet, C., P. Crepieux, and V. Laudet. 1997. Rel/NF-κB transcription factors and IκB inhibitors: evolution from unique common ancestor. Oncogene 15:2965.
20. Bours, V., G. Franzoso, V. Azarenko, S. Park, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 72:729.
21. Fujita, T., G. P. Nolan, H. C. Liou, M. L. Scott, and D. Baltimore. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev. 7:1354.
22. Fransozo, G., L. Carlson, T. Sharton-Kersten, E. W. Shores, S. Epstein, A. Grinber, T. Tran, E. Shacter, A. Leonardi, P. Love, A. Sher, and U. Siebenlist. 1997. Critical roles for trie bcl-3 oncoprotein in T-cell mediated immunity, splenic microarchitecture and germinal center formation. Immunity 6:479.
23. Schwartz, E. M., P. Krimpenfort, A. Berns, and I. M. Verma. 1997. Immunological defects in mice with targeted disruption in Bcl-3. Genes Dev. 11:187.
24. Kraal, G. 1992. Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132:31.
25. Kosco-Vilbois, M. H., H. Zentgraf, J. Gerdes, and J. Y. Bonnefoy. 1997. To "B" or not to "B" a germinal center? Immunol. Today 5:225.
26. Kraal, G., K. Schornagel, P. R. Streeter, B. Holzmann, and E. C. Butcher. 1995. Expression of mucosal vascular addressin, MAdCAM-1 on sinus-lining cells in the spleen. Am. J. Pathol. 147:763.
27. Szabo, M. C., E. Butcher, and L. M. McEvoy. 1997. Specialization of mucosal follicular dendritic cells revealed by mucosal addressin cell adhesion molecule-1 display. J. Immunol. 158:5584.
28. Chen, L. L., A. M. Frank, J. C. Adams, and R. M. Steinman. 1978. Distribution of horseradish peroxidase (HRP)-anti-HRP immune complexes in mouse spleen with special reference to follicular dendritic cells. J. Exp. Med. 79:184.
29. Szakal, A. K., M. H. Kosco, and J. G. Tew. 1988. A novel in vivo follicular dendritic cell-dependent icosome-mediated mechanism for delivery of antigen to antigen-processing cells. J. Immunol. 140:341.
30. Gunn, M. D., V. N. Ngo, K. M. Ansel, E. H. Ekland, J. G. Cyster, and L. T. Williams. 1998. A B-cell homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391:799.
31. Legler, D. F., M. Loetscher, R. S. Roos, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1998. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/ CXCR5. J. Exp .Med. 187:655.
32. Ngo, V. N., H. Korner, M. D. Gunn, K. N. Schmidt, D. S. Riminton, M. D. Cooper, J. L. Browning, J. D. Sedgwick, and J. G. Cyster. 1999. Lymphotoxin α and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189:403.
33. Fu, Y. X., G. Huang, Y. Wang, and D. D. Chaplin. 1998. B lymphocytes induce formation of follicular dendritic cell clusters in lymphotoxin α dependent fashion. J. Exp. Med. 187:1009.
34. Feuillard, J., M. Korner, A. Israel, J. Vassy, and M. Raphael. 1996. Differential nuclear localization of p50, p52 and RelB proteins in human accessory cells of the immune response in situ. Eur. J. Immunol. 26:2547.
35. Berg, E. L., L. M. McEvoy, C. Berlin, R. F. Bargatze, and E. C. Butcher. 1993. L-selectin mediated lymphocyte rolling on MAdCAM-1. Nature 366:695.
36. Gullberg, D., and P. Ekblom. 1995. Extracellular matrix and its receptors during development. Int. J. Dev. Biol. 39:845.
37. Ogata, T., M. Yamakawa, Y. Imai, and T. Takahashi. 1996. Follicular dendritic cells adhere to fibronectin and laminin fibres via their respective receptors. Blood 88:2995.
38. Shyy, J. Y., and S. Chien. 1997. Role of integrins in cellular response to mechanical stress and adhesion. Curr. Opin. Cell. Biol. 9:707.
39. 3 regulates synthesis of proteins in activated human platelets. J. Cell. Biol. 144:175.
40. Futterer, A., K. Mink, A. Luz, M. H. Kosco-Vilbois, and K. Pfeffer. 1998. The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9:59.
41. Matsumoto, M., Y.-X. Fu, H. Molina, G. Huang, J. Kim, D. A. Thomas, M. H. Nahm, and D. D. Chaplin 1997. Distinct roles of lymphotoxin α and the type 1 tumor necrosis factor (TNF) receptor in establishment of follicular dendritic cells from non-bone marrow-derived cells. J. Exp. Med. 186:1997.
42. Matsumoto, M., Y.-X. Fu, H. Molina, and D. Chaplin. 1997. Lymphotoxin-α-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers. Immunol. Rev. 156: 137.
43. Koni, P. A., R. Sacca, P. Lawton, J. L. Browning, N. H. Ruddle, and R. A. Flavell. 1997. Distinct roles in lymphoid organogenesis for lymphotoxin α and β revealed in lymphotoxin β-deficient mice. Immunity 6:491.